Apixaban for the prevention of venous thromboembolism in high-risk ambulatory cancer patients receiving chemotherapy: Rational and design of the AVERT trial

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: Thrombosis Research

Abbreviated Title: Thrombosis Research

Publisher: Elsevier BV

ISSN (Print): 00493848

Publication date Created: April 2018

Publication date (Print): April 2018

Volume: 164

Pages: S124-S129

Article

DOI: 10.1016/j.thromres.2018.01.018

SO-VID: c54343c3-104d-4af9-a4c2-18866568cea3

License:

https://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

Comments

Comment on this article

scite_

Cited by 11

See all cited by